Ignite Creation Date:
2024-05-06 @ 6:18 PM
Last Modification Date:
2024-10-26 @ 2:45 PM
Study NCT ID:
NCT05617560
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2022-11-07
Brief Title:
HospitalHome Telemedical Care After Inpatient Hospital Stay
Sponsor:
University Hospital Basel Switzerland
Organization:
University Hospital Basel Switzerland
Study Overview
Official Title:
HospitalHome Telemedical Care After Inpatient Hospital Stay
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This pilot study is to investigate a patient transfer path from the hospital to HospitalHome to their general practitioners GPs using telemedical procedures Telemedical support will be executed by Medgate who will refer the patients to their GPs after the telemedical consultations are completed Inclusion criteria is the need for short time follow up procedures that can be handled by telemedicine Throughout the study patient and stakeholder satisfaction will be measured and data-based methods will be developed to assess patient transfer success Overall new information flow and communication between the stakeholders hospital telemedicine and general practitioners are defined and tested The HospitalHome pilot study is intended to become a flagship project for new healthcare models
Detailed Description:
This pilot study is to investigate a patient transfer path from the hospital to HospitalHome to their general practitioners GPs using telemedical procedures
The following study procedures are depicted
Visit 1 screening Patients provide the name of their GP the means of transport that they usually take to him demographic data past medical history and current medications
The study team contacts the GP afterwards by phone to get hisher consent The study team informs Medgate about the participant and the procedure Next to that it will link Medgate technically to the case of the patient that Medgate can see the patients documentation in the University Hospital Basel USB -ePortal
Visit 2 transfer Before leaving the hospital the participant will be instructed by a member of the study team on how and when to fill out the questionnaires At this time the participant and the USB physician will answer the first one After Medgate has received the information from USB that the patient has been included in the study and has left the hospital the patient will be contacted by Medgate and the appointment for the first teleconsultation will be made according to information from USB The patient will be called by Medgate physician at the agreed time and the teleconsultation will be performed Depending on the patients condition and health status further appointments are scheduled The patient has the possibility to contact Medgate at any time 247 in case of an urgent medical matter The patient receives the physicians recommendations in written form after each teleconsultation as their treatment plan via app or e-mail
Visit 3x telecare In advance of the first consultation via Medgate the Medgate physician will log in into the USB-ePortal to get all important medical information about the patient After that consultation the patient and the Medgate physician will answer a questionnaire Depending on the clinical condition health status and from this resulted procedure the participant will be contacted several times After the last consultation the Medgate physician will answer a questionnaire and will refer the patient back to the GP The documentation will be sent to the GP and the USB The GP will get a questionnaire as well
Visit 4 follow-up On day x after the last consultation via Medgate the GP and the participant will answer the last questionnaire
The following study procedures are depicted
Visit 1 screening Patients provide the name of their GP the means of transport that they usually take to him demographic data past medical history and current medications
The study team contacts the GP afterwards by phone to get hisher consent The study team informs Medgate about the participant and the procedure Next to that it will link Medgate technically to the case of the patient that Medgate can see the patients documentation in the University Hospital Basel USB -ePortal
Visit 2 transfer Before leaving the hospital the participant will be instructed by a member of the study team on how and when to fill out the questionnaires At this time the participant and the USB physician will answer the first one After Medgate has received the information from USB that the patient has been included in the study and has left the hospital the patient will be contacted by Medgate and the appointment for the first teleconsultation will be made according to information from USB The patient will be called by Medgate physician at the agreed time and the teleconsultation will be performed Depending on the patients condition and health status further appointments are scheduled The patient has the possibility to contact Medgate at any time 247 in case of an urgent medical matter The patient receives the physicians recommendations in written form after each teleconsultation as their treatment plan via app or e-mail
Visit 3x telecare In advance of the first consultation via Medgate the Medgate physician will log in into the USB-ePortal to get all important medical information about the patient After that consultation the patient and the Medgate physician will answer a questionnaire Depending on the clinical condition health status and from this resulted procedure the participant will be contacted several times After the last consultation the Medgate physician will answer a questionnaire and will refer the patient back to the GP The documentation will be sent to the GP and the USB The GP will get a questionnaire as well
Visit 4 follow-up On day x after the last consultation via Medgate the GP and the participant will answer the last questionnaire
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None